Form 4: Alignment Healthcare CEO John Kao Reports Stock Transactions Following PSU Vesting

Alignment Healthcare's CEO, John Kao, reports acquiring shares from vested performance share units (PSUs) and selling shares to cover tax obligations.

Summary

• On March 4, 2025, Alignment Healthcare CEO John Kao acquired 2,543,124 shares of common stock upon the vesting of performance share units (PSUs).
• The PSUs vested based on the achievement of performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA less capital expenditures.
• 50% of the granted PSUs vested on March 4, 2025, and the remaining 50% will vest on December 31, 2025, contingent upon continued service.
• On March 6, 2025, Mr. Kao sold 554,713 shares at an average price of $15.53 to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Mr. Kao directly owns 4,733,664 shares and indirectly owns 2,183,100 shares through the JEK Trust dated February 8, 2021.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The vesting of PSUs indicates the company is meeting its performance goals. However, the subsequent sale of shares, even for tax purposes, introduces a slight element of uncertainty.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance objectives related to revenue growth, medical benefit ratio, and adjusted EBITDA less capital expenditures.
• The achievement of performance objectives above target suggests positive operational performance for the company.

Negatives

• The sale of 554,713 shares by the CEO, even for tax obligations, could be perceived negatively by some investors, although it's a common practice after vesting events.

Risks

• Future vesting of the remaining 50% of PSUs on December 31, 2025, is contingent upon Mr. Kao's continued service to the company.
• The market's reaction to insider selling, even for tax purposes, can be unpredictable and may temporarily affect the stock price.

Future Outlook

50% of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

This filing is a routine disclosure of insider transactions. The vesting of PSUs suggests that Alignment Healthcare is meeting its performance targets, which is a positive signal for investors in the healthcare services industry. Monitoring insider transactions can provide insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• Comparing Alignment Healthcare's performance metrics (revenue growth, medical benefit ratio, EBITDA) to those of competitors like Humana, UnitedHealth Group, and CVS Health can provide a benchmark for assessing its operational efficiency and profitability.
• The structure of Alignment Healthcare's PSU grants, with vesting tied to specific financial and operational targets, is a common practice among publicly traded companies to align management incentives with shareholder value creation.

Stakeholder Impact

• Shareholders may view the PSU vesting as a positive sign of company performance.
• Employees may be motivated by the achievement of performance targets and the potential for future PSU vesting.
• The sale of shares by the CEO could create short-term price volatility.

Next Steps

• Monitor Alignment Healthcare's stock performance following the disclosure of these transactions.
• Track the company's progress towards achieving the performance targets for the remaining PSUs that will vest on December 31, 2025.

Key Dates